Literature DB >> 31691127

Long Noncoding RNA HOTAIRM1 Maintains Tumorigenicity of Glioblastoma Stem-Like Cells Through Regulation of HOX Gene Expression.

Hongping Xia1,2,3, Yinhua Liu4, Zhichun Wang5, Wei Zhang4, Min Qi5, Bin Qi6, Xiaochun Jiang7.   

Abstract

Noncoding RNAs regulate transcription of gene expression and play an important role in the pathogenesis of glioblastomas. These tumors are heterogeneous with some glioma stem cells (GSCs) that are highly tumorigenic subpopulations of cells contributing to recurrence and treatment resistance. In this study, GSCs were established by neurosphere cultures of primary glioblastoma cells and validated by the expression of GSC marker CD133. The expression of the long noncoding RNA HOTAIRM1 was detected using real-time quantitative reverse transcription PCR (qRT-PCR). The role of HOTAIRM1 in the proliferation, apoptosis, stemness, and tumorigenicity of GSCs was investigated by soft agar colony formation, flow cytometry, TUNEL analysis, sphere formation, and in vivo xenograft models through silencing of HOTAIRM1. The expression of HOTAIRM1 and the neighboring HOX genes were analyzed by qRT-PCR in different grades of gliomas and nontumor tissues. We found that HOTAIRM1 is significantly elevated in GSCs. The silencing of HOTAIRM1 significantly impairs the proliferation, apoptosis, self-renewal, tumorigenesis of GSCs. In addition, HOTAIRM1 is significantly upregulated in gliomas and associated with tumor grade and patient survival. HOTAIRM1 neighboring genes, HOXA1, HOXA2, and HOXA3, are also significantly upregulated in gliomas and correlate with the expression of HOTAIRM1. Among them, HOXA2 and HOXA3 were identified as being upregulated in GSCs and contributed to the self-renewal of these stem cells. Taken together, our results demonstrate that HOTAIRM1 plays a critical role in the self-renewal of GSCs. These data also suggest that overexpression of HOTAIRM1 can be a negative prognostic factor for patient survival in malignant glioma and may be a promising potential therapeutic target.

Entities:  

Keywords:  CD133; Glioblastoma stem cells; HOTAIRM1; HOX genes; LncRNAs

Mesh:

Substances:

Year:  2020        PMID: 31691127      PMCID: PMC7283434          DOI: 10.1007/s13311-019-00799-0

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  2 in total

1.  Long non-coding RNA expression profiles predict clinical phenotypes in glioma.

Authors:  Xiaoqin Zhang; Stella Sun; Jenny Kan Suen Pu; Anderson Chun On Tsang; Derek Lee; Venus On Ying Man; Wai Man Lui; Stanley Thian Sze Wong; Gilberto Ka Kit Leung
Journal:  Neurobiol Dis       Date:  2012-06-16       Impact factor: 5.996

2.  Differential lncRNA expression profiles in recurrent gliomas compared with primary gliomas identified by microarray analysis.

Authors:  Yi Chen; Jian-Jin Wu; Xian-Bin Lin; Yi Bao; Zhen-Hua Chen; Cheng-Ran Zhang; Zheng Cai; Jue-Yu Zhou; Mao-Hua Ding; Xiao-Jun Wu; Wei Sun; Jun Qian; Lei Zhang; Lei Jiang; Guo-Han Hu
Journal:  Int J Clin Exp Med       Date:  2015-04-15
  2 in total
  8 in total

1.  The Long Non-Coding RNA HOXA-AS2 Promotes Proliferation of Glioma Stem Cells and Modulates Their Inflammation Pathway Mainly through Post-Transcriptional Regulation.

Authors:  Elisa Le Boiteux; Pierre-Olivier Guichet; Konstantin Masliantsev; Bertille Montibus; Catherine Vaurs-Barriere; Céline Gonthier-Gueret; Emmanuel Chautard; Pierre Verrelle; Lucie Karayan-Tapon; Anne Fogli; Franck Court; Philippe Arnaud
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

2.  HOTAIRM1 Maintained the Malignant Phenotype of tMSCs Transformed by GSCs via E2F7 by Binding to FUS.

Authors:  Liang Liu; Yanling Zhou; Xuchen Dong; Suwen Li; Shan Cheng; Haoran Li; Yongdong Li; Jiaqi Yuan; Liping Wang; Jun Dong
Journal:  J Oncol       Date:  2022-05-09       Impact factor: 4.501

Review 3.  Evolving Insights Into the Biological Function and Clinical Significance of Long Noncoding RNA in Glioblastoma.

Authors:  Kun Liu; Hong Chen; Yuanyuan Wang; Liping Jiang; Yi Li
Journal:  Front Cell Dev Biol       Date:  2022-04-21

4.  Targeting HOTAIRM1 ameliorates glioblastoma by disrupting mitochondrial oxidative phosphorylation and serine metabolism.

Authors:  Wei Han; Shanshan Wang; Yingjiao Qi; Fan Wu; Ningyu Tian; Boqin Qiang; Xiaozhong Peng
Journal:  iScience       Date:  2022-07-31

5.  A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.

Authors:  Zhirui Zeng; Chujiao Hu; Wanyuan Ruan; Jinjuan Zhang; Shan Lei; Yushi Yang; Pailan Peng; Feng Pan; Tengxiang Chen
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

6.  The LncRNA RP11-279C4.1 Enhances the Malignant Behaviour of Glioma Cells and Glioma Stem-Like Cells by Regulating the miR-1273g-3p/CBX3 Axis.

Authors:  Faming Wang; Le Zhang; Yao Luo; Qingyun Zhang; Yueling Zhang; Yingying Shao; Liudi Yuan
Journal:  Mol Neurobiol       Date:  2021-03-10       Impact factor: 5.590

Review 7.  Roles of Long Noncoding RNAs in Conferring Glioma Progression and Treatment.

Authors:  Jie Qin; Chuanlu Jiang; Jinquan Cai; Xiangqi Meng
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

Review 8.  Noncoding RNAs in Glioblastoma: Emerging Biological Concepts and Potential Therapeutic Implications.

Authors:  Uswa Shahzad; Stacey Krumholtz; James T Rutka; Sunit Das
Journal:  Cancers (Basel)       Date:  2021-03-28       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.